.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Accenture
Baxter
US Department of Justice
McKinsey
Daiichi Sankyo
Cipla
Fuji
Moodys
Novartis

Generated: June 23, 2017

DrugPatentWatch Database Preview

DIPROSONE Drug Profile

« Back to Dashboard

What is the patent landscape for Diprosone, and when can generic versions of Diprosone launch?

Diprosone is a drug marketed by Schering and is included in four NDAs.

The generic ingredient in DIPROSONE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

Summary for Tradename: DIPROSONE

Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: see list29
Clinical Trials: see list4
Patent Applications: see list1,995
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIPROSONE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
DIPROSONE
betamethasone dipropionate
DISC;TOPICAL017829-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Schering
DIPROSONE
betamethasone dipropionate
OINTMENT;TOPICAL017691-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Schering
DIPROSONE
betamethasone dipropionate
CREAM;TOPICAL017536-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Schering
DIPROSONE
betamethasone dipropionate
LOTION;TOPICAL017781-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
US Army
Johnson and Johnson
Cipla
McKinsey
Healthtrust
Deloitte
Queensland Health
Accenture
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot